CLIMB BIO INC (CLYM) Stock Analyst Ratings
NASDAQ:CLYM - Nasdaq - US28658R1068 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 88% to CLYM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 507.14% above the current price.
CLYM was analyzed by 8 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about CLYM.
In the previous month the buy percentage consensus was at a similar level.
CLYM was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-06 | Oppenheimer | Initiate | Outperform |